Skip to main navigation menu Skip to main content Skip to site footer

Glucose-6-phosphate dehydrogenase: biochemical and molecular characteristics. Prevalence of deficiency

Glucosa 6 fosfato deshidrogenasa: características bioquímicas y moleculares. Prevalencia de la deficiencia




Section
Artículos de Revisión

How to Cite
Bastidas Pacheco, G. A., Pérez, H., & Vizzi, E. (2015). Glucose-6-phosphate dehydrogenase: biochemical and molecular characteristics. Prevalence of deficiency. Archivos De Medicina , 15(1), 138-150. https://doi.org/10.30554/archmed.15.1.667.2015
Download Citation

Dimensions
PlumX

How to Cite

Bastidas Pacheco, G. A., Pérez, H., & Vizzi, E. (2015). Glucose-6-phosphate dehydrogenase: biochemical and molecular characteristics. Prevalence of deficiency. Archivos De Medicina , 15(1), 138-150. https://doi.org/10.30554/archmed.15.1.667.2015

Download Citation

Gilberto Antonio Bastidas Pacheco
Hilda Pérez
Esmeralda Vizzi

Gilberto Antonio Bastidas Pacheco,

Médico, master en gerencia de la educación, master en protozoologia, doctor en parasitologia. con diplomados en alta gerencia y salud laboral. Profesor asociado departamento de salud publica, escuela de medicina, facultad de ciencias de la salud.


Hilda Pérez,

Biologa con doctorado en inmunologia.

Esmeralda Vizzi,

Biologa con doctorado en biologia molecular.

Glucose-6-phosphate dehydrogenase (G6PD) is a cytoplasmic enzyme that is distributed in all cells of the organism and that catalyzes the first step in the pentose pathway in which glucose-6-phosphate (G6P) is converted to 6-fosfogluconato (6FG)
and reduced NADP to NADPH, which is essential to protect erythrocytes from oxidative damage process. The G6PD deficiency is the most common erythroenzymopathy, is
recessive and X-linked, with worldwide distribution and high genetic and biochemical heterogeneity. A review of biochemical aspects, structure, genetics, molecular, enzymatic
defect, prevalence of disability in the world and in Venezuela, and the role of G6PD deficiency in the treatment of malaria was conducted by the increased risk of hemolysis involves the tendency to increase the total dose of primaquine in subjects
malaria, particularly in regions where infection by Plasmodium vivax predominates.

Article visits 4639 | PDF visits 1288


Downloads

Download data is not yet available.
Sistema OJS 3.4.0.10 - Metabiblioteca |